Results 111 to 120 of about 76,328,651 (141)

Exploring C4-Modified Sialosides in Siglec Affinity and Selectivity

open access: yes, 2018
The family of Sialic-acid-binding ImmunoGlobulin-like LECtins, known as Siglecs, play a vital role in the hematopoietic, immune and nervous systems of many mammals, including humans.
Madge, Paul
core   +1 more source

Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg)

open access: yes, 2008
Human intravenous immunoglobulins (IVIg) contain natural autoantibodies against the inhibitory lectin-receptors Siglec-8 and Siglec-9. These two members of the Siglec family are known to mediate both inhibitory and death signals.
Simon, Hans-Uwe   +5 more
core   +1 more source

Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.

open access: yesPLoS ONE
Breast cancer (BRCA) is among the most prevalent cancers and is responsible for numerous patient fatalities. Immunotherapy has emerged as a promising approach to cancer treatment.
Huan Lai   +5 more
doaj   +1 more source

Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2023
Moreira RS   +8 more
europepmc   +1 more source

Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion [PDF]

open access: yes
Neisserial adhesin A (NadA) is a meningococcal surface protein included as recombinant antigen in 4CMenB, a protein-based vaccine able to induce protective immune responses against Neisseria meningitidis serogroup B (MenB).
Perrotta, A   +37 more
core   +1 more source

Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies

open access: yes, 2007
BACKGROUND: Human intravenous immunoglobulin (IVIg) preparations are used for the treatment of autoimmune and allergic diseases. Natural autoantibodies are believed to contribute to IVIg-mediated anti-inflammatory effects.
Schaub, Alexander   +22 more
core   +1 more source

Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia. [PDF]

open access: yesCancer Res Commun, 2023
Pillsbury CE   +18 more
europepmc   +1 more source

Mechanisms of tumor immune escape mediated by Siglec-15 and advances and prospects in targeted therapy

open access: yesZhongguo aizheng zazhi
Immune checkpoint blockade targeting the programmed cell death protein-1 (PD-1) and its ligand PD-L1 has revolutionized cancer immunotherapy; however, a substantial proportion of patients exhibit primary or acquired resistance, underscoring the existence
WANG Shihui, ZHENG Tianqing
doaj  

Siglec-15 Expression in Gastric Carcinoma and Its Association With Clinicopathological Variables. [PDF]

open access: yesWorld J Oncol
Al Badr S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy